| Income Statement |
| Operating Expenses | 4.72M |
|
| Research and Development Expense | 2.37M |
| Selling, General and Administrative Expense | 2.35M |
| Operating Income | -4.72M |
| Net Income | -4.70M |
| Net Income Common Stock | -4.70M |
| Net Income Common Stock (USD) | -4.70M |
| Consolidated Income | -4.70M |
| Earnings per Basic Share | -0.12 |
| Earnings per Basic Share (USD) | -0.12 |
| Earnings per Diluted Share | -0.12 |
| Earning Before Interest & Taxes (EBIT) | -4.70M |
| Earning Before Interest & Taxes (USD) | -4.70M |
| Weighted Average Shares | 40.59M |
| Weighted Average Shares Diluted | 40.59M |
| Balance Sheet |
| Cash and Equivalents | 2.04M |
| Cash and Equivalents (USD) | 2.04M |
| Current Assets | 2.44M |
| Property, Plant & Equipment Net | 1.44M |
| Total Assets | 3.93M |
| Current Liabilities | 3.29M |
| Total Liabilities | 3.29M |
| Accumulated Retained Earnings (Deficit) | -81.99M |
| Shareholders Equity | 635.00K |
| Shareholders Equity (USD) | 635.00K |
| Assets Non-Current | 1.49M |
| Inventory | 133.00K |
| Trade and Non-Trade Payables | 747.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 24.00K |
| Net Cash Flow from Financing | 1.52M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.34M |
| Capital Expenditure | -246.00K |
| Issuance (Purchase) of Equity Shares | 1.52M |
| Net Cash Flow from Investing | -246.00K |
| Net Cash Flow from Operations | -3.61M |
| Share Based Compensation | 1.22M |